Breaking: Pfizer settles Vyndamax (tafamidis) suit

It has been confirmed today that Pfizer settled with the final defendant, Hikma Pharmaceuticals.

Next
Next

Jazz Pharmaceuticals' Ziihera wins FDA priority review for first-line gastric cancer use